Bone marrow transplantation for Philadelphia-chromosome-positive acute lymphoblastic leukemia.

@article{Stockschlaeder1995BoneMT,
  title={Bone marrow transplantation for Philadelphia-chromosome-positive acute lymphoblastic leukemia.},
  author={Marcus Stockschlaeder and Susanna Hegewisch-Becker and W. Kr{\"u}ger and A tom Dieck and Klaus G Mross and M. M. Hoffknecht and Carolina Berger and Brigitte Kohlsch{\"u}tter and Heather Martin and Sara Peters},
  journal={Bone marrow transplantation},
  year={1995},
  volume={16 5},
  pages={663-7}
}
The outcome of 14 bone marrow transplants (BMT) (autologous 4; allogeneic 10) for Philadelphia-chromosome (Ph1) positive acute lymphoblastic leukemia (ALL) was analyzed. Preparative regimens consisted of etoposide (VP16) (30 or 45 mg/kg BW) (n = 14), cyclophosphamide (CY)(120 mg/kg BW) (n = 14), and total body irradiation (TBI)(12 Gy) (n = 13) or busulfan (Bu)(16 mg/kg) (n = 1). All patients receiving autologous marrow were in complete remission (CR) (three patients in 1.CR, one patient in 2.CR… CONTINUE READING